Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$813K Buy
+4,905
New +$913K 0.32% 38
2025
Q2
Sell
-5,771
Closed -$965K 51
2025
Q1
$965K Sell
5,771
-8,569
-60% -$1.34M 0.38% 31
2024
Q4
$2.08M Buy
14,340
+100
+0.7% +$15.3K 0.72% 31
2024
Q3
$2.1M Buy
14,240
+1,900
+15% +$283K 0.76% 32
2024
Q2
$1.93M Sell
12,340
-4,662
-27% -$743K 0.71% 31
2024
Q1
$2.68M Buy
17,002
+8,832
+108% +$1.33M 0.97% 31
2023
Q4
$1.22M Buy
+8,170
New +$1.24M 0.47% 43

Other funds holding CVX

Altrafin AG's CVX Position: Q2 2026 in Review

Altrafin AG opened a new position in Chevron (CVX) in Q2 2026: 4,905 shares worth $813K. The stake represents 0.32% of the portfolio and ranks #38 among its holdings. This is a return to the name: Altrafin AG previously reported a position in CVX as recently as Q1 2025.

Altrafin AG first reported a position in CVX in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.68M in Q1 2024. 4,115 funds tracked by Wall St. Rank hold CVX as of Q2 2026.

  • Altrafin AG held 4,905 shares of Chevron worth $813K as of Q2 2026.
  • Chevron was a new Altrafin AG position in Q2 2026.
  • Chevron made up 0.32% of Altrafin AG's portfolio in Q2 2026, its #38 holding.
  • Altrafin AG first reported a position in Chevron in Q4 2023 and has held it in 7 quarters since.
  • Altrafin AG's Chevron position peaked at $2.68M in Q1 2024.
  • 4,115 funds tracked by Wall St. Rank held Chevron as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.